Research review
Does myo-inositol help with PCOS? What the research does and doesn't show
The systematic review behind the 2023 international PCOS guidelines called inositol's evidence limited and inconclusive, while smaller placebo-controlled trials found lower testosterone, better insulin measures and higher ovulation rates with myo-inositol or D-chiro-inositol.
The evidence doesn't clearly support myo-inositol as an established PCOS treatment — the largest review behind the 2023 international PCOS guidelines called the evidence "limited and inconclusive." It does show myo-inositol lowering some hormone and metabolic markers compared with placebo in smaller trials, and one review found it increased ovulation rates in women with PCOS and infertility, with moderate certainty.
What the evidence doesn't support
It doesn't support myo-inositol as a proven treatment for PCOS. The systematic review conducted to inform the 2023 international evidence-based PCOS guidelines pooled 30 trials and 2,230 women and concluded that "the evidence supporting the use of inositol in the management of PCOS is limited and inconclusive," recommending that clinicians and patients weigh that uncertainty in any shared decision. It doesn't support a specific dose as the correct one — trials have used doses from about 2 to 4 grams of myo-inositol a day, sometimes alone and sometimes combined with D-chiro-inositol, without a single dose emerging as standard. And it doesn't support myo-inositol for every PCOS symptom: some outcomes measured across trials showed no effect at all.
What the trials found
The picture is genuinely mixed, and it depends on which review and which outcome. The 2024 guideline-informing review (30 trials, n=2,230) found myo-inositol or D-chiro-inositol showed benefit for some metabolic measures and D-chiro-inositol specifically showed a potential benefit for ovulation, but reported no effect on several other outcomes, and rated the overall evidence quality as low to very low across most comparisons. A separate 2023 meta-analysis of 26 randomized trials (n=1,691, including 806 on inositol and 311 on placebo) found that, compared with placebo, inositol was associated with a higher rate of regular menstrual cycles, a lower BMI (mean difference −0.45), lower free testosterone (−0.41) and total testosterone, lower androstenedione, lower fasting glucose and lower insulin AUC (area under the curve, a measure of insulin response over time), and a rise in sex-hormone-binding globulin, which binds testosterone and can lower the free, active amount in circulation.
A broader 2023 umbrella review, which pooled multiple meta-analyses across several PCOS supplements, rated the evidence for inositol improving fasting insulin as moderate certainty, and separately rated inositol increasing ovulation rates in subfertile women with PCOS as moderate certainty too — one of the few findings in that umbrella review to reach that level, most supplement effects being rated low or very low certainty. None of the reviews found consistent evidence that myo-inositol improves every reproductive or metabolic marker measured in PCOS research, and none reports a single agreed dose across trials; total daily intake in the trials pooled by these reviews commonly fell in a 2-4 gram range.
| Outcome | What the research found | Certainty |
|---|---|---|
| Menstrual cycle regularity | Higher with inositol vs. placebo (26-trial meta-analysis) | Not separately graded; guideline review calls overall inositol evidence low-to-very-low |
| Ovulation (in subfertile women) | Increased with inositol (umbrella review); D-chiro-inositol specifically flagged in the guideline review | Moderate |
| Fasting insulin | Improved with inositol (umbrella review) | Moderate |
| Testosterone, androstenedione, BMI, fasting glucose | Lower with inositol vs. placebo (26-trial meta-analysis) | Not separately graded |
| Overall PCOS management | "Limited and inconclusive" (2024 guideline review, 30 trials) | Low to very low across most comparisons |
Questions people ask
Does myo-inositol help with PCOS?
The research is mixed rather than a clear yes or no. Some meta-analyses report lower testosterone, better insulin measures, more regular cycles and higher ovulation rates with myo-inositol compared with placebo, while the review that informed the 2023 international PCOS guidelines called the overall evidence "limited and inconclusive." Both things are true at once: some positive signals exist, and the certainty behind most of them is low.
How much myo-inositol should I take for PCOS?
There's no single dose established as correct. Trials reviewed here commonly used around 2 to 4 grams of myo-inositol a day, sometimes combined with D-chiro-inositol, over periods of a few months to about a year. A specific number pulled from one trial and applied generally would be a guess, not a guideline.
Does myo-inositol help with PCOS-related weight?
One 26-trial meta-analysis found a small average difference in BMI favoring inositol over placebo (mean difference −0.45), but the larger 2024 guideline review rated the evidence for body-mass outcomes as very uncertain. This isn't strong enough evidence to describe myo-inositol as a weight-loss supplement for PCOS.
Does myo-inositol help PCOS hair loss or acne?
None of the reviews summarized here measured hair loss or acne directly. The hormone changes reported — lower testosterone and androstenedione — are markers linked to those symptoms in PCOS generally, but no trial in this review measured hair or skin outcomes themselves.
Is myo-inositol the same as inositol or D-chiro-inositol?
No. Myo-inositol and D-chiro-inositol are both forms of inositol, a nutrient-like compound, and they aren't interchangeable in the research — the 2024 guideline review specifically flagged D-chiro-inositol, not myo-inositol, for a potential ovulation benefit, while other outcomes were measured for myo-inositol, D-chiro-inositol or combinations of both. Trials aren't consistent about which form, or which ratio of the two, they test.
Can I take myo-inositol without other PCOS supplements?
The trials reviewed above tested myo-inositol on its own or combined with D-chiro-inositol, not typically stacked with other PCOS supplements as a routine. Whether adding other ingredients changes the picture isn't answered by this research; see our broader review of PCOS supplement research for how other ingredients have been studied separately.
When to talk to a doctor
PCOS is a diagnosed hormonal condition, and myo-inositol is not an established treatment for it — the evidence above is mixed, and the review that informs current clinical guidelines calls it inconclusive. Diagnosis, monitoring and any treatment decision belong with a doctor, particularly for symptoms like irregular periods, difficulty conceiving, or signs of insulin resistance. If you are pregnant, trying to conceive, or taking any medication, talk to a doctor before starting myo-inositol or any other supplement.
Related reading: PCOS supplements: what the research does and doesn't show and does berberine help with PCOS? what the research does and doesn't show.
Sources
- Inositol for Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis to Inform the 2023 Update of the International Evidence-based PCOS Guidelines The review behind the 2023 international PCOS guidelines pooled 30 trials and called the overall evidence for inositol in PCOS management limited and inconclusive, though it flagged possible benefits for some metabolic measures and, for D-chiro-inositol specifically, ovulation.
- Inositol is an effective and safe treatment in polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials A meta-analysis of 26 randomized trials found lower testosterone, androstenedione, fasting glucose and insulin-response measures, and more regular cycles, with inositol compared with placebo in women with PCOS.
- Effects of nutrition on metabolic and endocrine outcomes in women with polycystic ovary syndrome: an umbrella review of meta-analyses of randomized controlled trials An umbrella review of 28 PCOS nutrition meta-analyses found no high-certainty evidence for any dietary or supplement intervention, though probiotics, omega-3, vitamin D, inositol and curcumin showed moderate-to-high certainty effects on specific insulin, glucose or lipid markers.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.